PowerShares Dynamic Pharmaceuticals(ETF)  

(Public, NYSEARCA:PJP)   Watch this stock  
Find more results for PJP
43.31
+0.23 (0.53%)
Real-time:   12:24PM EDT
NYSEARCA real-time data - Disclaimer
Currency in USD
Range 42.50 - 43.31
52 week 30.13 - 44.02
Open 42.59
Vol. 25,877.00
Mkt cap 504.56M
P/E 8.08
Div/yield 0.01/1.25
EPS 5.36
Shares 11.65M
Beta 0.69
Inst. own 29%

Key stats and ratios

Q4 (Oct '12) 2012
Net profit margin 369.05% 1363.11%
Operating margin 77.23% 54.92%
EBITD margin - 54.92%
Return on average assets 10.01% 21.18%
Return on average equity 10.10% 21.51%
Carbon Disclosure Rating - -

Address

301 W. Roosevelt Road
Wheaton, IL 60187
United States - Map
+1-800-9830903 (Phone)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money
Discussion Group - Google Finance

Description

PowerShares Dynamic Pharmaceuticals Portfolio (the Fund) is a non-diversified fund. The Fund seeks investment results that correspond generally to the price and yield of the Dynamic Pharmaceuticals Intellidex Index (the Index). The Index evaluates companies based on a variety of investment merit criteria, including fundamental growth, stock valuation, investment timeliness and risk factors. The Index consists of stocks of 30 United States pharmaceutical companies. These are companies that are principally engaged in the research, development, manufacture, sale or distribution of pharmaceuticals and drugs of all types. The Fund normally invests at least 90% of its total assets in common stocks that consists of the Index. The Fund�s investment advisor is Invesco PowerShares Capital Management LLC.

Officers and directors

H. Bruce Bond Chairman of the Board of Trustee, Chief Executive Officer
Age: 49
Bio & Compensation  - Reuters
Bruce T. Duncan Chief Financial Officer, Treasurer
Age: 56
Bio & Compensation  - Reuters
Kevin R. Gustafson Chief Compliance Officer
Age: 41
Bio & Compensation  - Reuters
Keith Ovitt Secretary
Age: 44
Bio & Compensation  - Reuters
Ronn R. Bagge Trustee
Age: 55
Bio & Compensation  - Reuters
Marc M. Kole Trustee
Age: 52
Bio & Compensation  - Reuters
D. Mark McMillan Trustee
Age: 44
Bio & Compensation  - Reuters
Philip M. Nussbaum Trustee
Age: 51
Bio & Compensation  - Reuters
Donald H. Wilson Trustee
Age: 53
Bio & Compensation  - Reuters